Therefore, the upregulation of PD-Ls in cHL may be due to genetic alterations involving 9p24.1 (e.g., by causing changes in the copy number of PD-L1/PD-L2/JAK2), to EBV infection, or even a combined result of both events. The gene discussed is PDCD1LG2; the disease is classic Hodgkin lymphoma.